{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:32:58Z","timestamp":1792783978644,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Suzhou Health and Family Planning Commission","award":["LCZX201728"],"award-info":[{"award-number":["LCZX201728"]}],"id":[{"id":"https:\/\/ror.org\/044bb5p62","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Suzhou National New & Hi-Tech Industrial Development Zone","award":["2017Z008"],"award-info":[{"award-number":["2017Z008"]}]},{"name":"international joint project in National Natural Science Foundation of China","award":["81720108026"],"award-info":[{"award-number":["81720108026"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s11046-020-00448-7","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T08:54:10Z","timestamp":1626339250000},"page":"527-535","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Molecular Identification and In Vitro Antifungal Susceptibility of Aspergillus Isolates Recovered from Otomycosis Patients in Western China"],"prefix":"10.1007","volume":"185","author":[{"given":"LiLi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos","family":"Houbraken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanqing","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadiliya","family":"Hasimu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weida","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9256-3868","authenticated-orcid":false,"given":"Shuwen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,28]]},"reference":[{"issue":"2","key":"448_CR1","first-page":"57","volume":"5","author":"HSVB Satish","year":"2013","unstructured":"Satish HSVB, Manjuladevi M. A clinical study of otomycosis. J Dent Med Sci. 2013;5(2):57\u201362.","journal-title":"J Dent Med Sci"},{"issue":"5","key":"448_CR2","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/j.1439-0507.2011.02132.x","volume":"55","author":"X Jia","year":"2012","unstructured":"Jia X, Liang Q, Chi F, Cao W. Otomycosis in Shanghai: aetiology, clinical features and therapy. Mycoses. 2012;55(5):404\u20139. https:\/\/doi.org\/10.1111\/j.1439-0507.2011.02132.x.","journal-title":"Mycoses"},{"key":"448_CR3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11046-011-9427-5","volume":"172","author":"LAML Garcia-Agudo","year":"2011","unstructured":"Garcia-Agudo LAML, Galan-Sanchez F, Garcia-Martos P, Marin-Casanova P, Rodrigues-Iglesias M. Otomycosis due to filamentous fungi. Mycopathologia. 2011;172:307\u201310.","journal-title":"Mycopathologia"},{"issue":"1","key":"448_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1439-0507.2007.01441.x","volume":"51","author":"J Fasunla","year":"2008","unstructured":"Fasunla J, Ibekwe T, Onakoya P. Otomycosis in western Nigeria. Mycoses. 2008;51(1):67\u201370. https:\/\/doi.org\/10.1111\/j.1439-0507.2007.01441.x.","journal-title":"Mycoses"},{"key":"448_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.ijporl.2007.12.005","volume":"72","author":"RDS Munguia","year":"2008","unstructured":"Munguia RDS. Ototopical antifungals and otomycosis: a review. Int J Pediatr Otorhinolaryngol. 2008;72:453\u20139.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"3","key":"448_CR6","doi-asserted-by":"publisher","first-page":"564","DOI":"10.12669\/pjms.303.4106","volume":"30","author":"K Anwar","year":"2014","unstructured":"Anwar K, Gohar MS. Otomycosis; clinical features, predisposing factors and treatment implications. Pak J Med Sci. 2014;30(3):564\u20137. https:\/\/doi.org\/10.12669\/pjms.303.4106.","journal-title":"Pak J Med Sci"},{"issue":"12","key":"448_CR7","first-page":"873","volume":"13","author":"B Barati","year":"2011","unstructured":"Barati B, Okhovvat SA, Goljanian A, Omrani MR. Otomycosis in central iran: a clinical and mycological study. Iran Red Crescent Med J. 2011;13(12):873\u20136.","journal-title":"Iran Red Crescent Med J"},{"key":"448_CR8","first-page":"486","volume":"63","author":"HHS Ishidaira","year":"2014","unstructured":"Ishidaira HHS, Nagai K, Tamura Y, Takano M, Sakai T. Epidemiological study of the isolation of Aspergillus species from 2000 to 2011 at Nagaoka Red Cross Hospital. Igakukensa. 2014;63:486\u201391.","journal-title":"Igakukensa"},{"issue":"11\u201312","key":"448_CR9","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1046\/j.1439-0507.2001.00689.x","volume":"44","author":"PFA Kurnatowski","year":"2001","unstructured":"Kurnatowski PFA. Otomycosis: prevalence, clinical symptoms, therapeutic procedure. Mycoses. 2001;44(11\u201312):472\u20139.","journal-title":"Mycoses"},{"issue":"8","key":"448_CR10","first-page":"12","volume":"2","author":"PPJ Panchal","year":"2013","unstructured":"Panchal PPJ, Patel D, Rathod S, Shah P. Analysis of various fungal agents in clinically suspected cases of otomycosis. Indian J Basic Appl Med Res. 2013;2(8):12\u20139.","journal-title":"Indian J Basic Appl Med Res"},{"issue":"6","key":"448_CR11","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.ijporl.2010.03.001","volume":"74","author":"KR Aneja","year":"2010","unstructured":"Aneja KR, Sharma C, Joshi R. Fungal infection of the ear: a common problem in the north eastern part of Haryana. Int J Pediatr Otorhinolaryngol. 2010;74(6):604\u20137. https:\/\/doi.org\/10.1016\/j.ijporl.2010.03.001.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"448_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3114\/sim.2007.59.05","volume":"59","author":"SA Balajee","year":"2007","unstructured":"Balajee SA, Houbraken J, Verweij PE, Hong SB, Yaghuchi T, Varga J, et al. Aspergillus species identification in the clinical setting. Stud Mycol. 2007;59:39\u201346. https:\/\/doi.org\/10.3114\/sim.2007.59.05.","journal-title":"Stud Mycol"},{"key":"448_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3114\/sim.2007.59.13","volume":"59","author":"RA Samson","year":"2007","unstructured":"Samson RA, Noonim P, Meijer M, Houbraken J, Frisvad JC, Varga J. Diagnostic tools to identify black aspergilli. Stud Mycol. 2007;59:129\u201345. https:\/\/doi.org\/10.3114\/sim.2007.59.13.","journal-title":"Stud Mycol"},{"issue":"4","key":"448_CR14","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1439-0507.2011.02103.x","volume":"55","author":"G Szigeti","year":"2012","unstructured":"Szigeti G, Sedaghati E, Mahmoudabadi AZ, Naseri A, Kocsube S, Vagvolgyi C, et al. Species assignment and antifungal susceptibilities of black aspergilli recovered from otomycosis cases in Iran. Mycoses. 2012;55(4):333\u20138. https:\/\/doi.org\/10.1111\/j.1439-0507.2011.02103.x.","journal-title":"Mycoses"},{"issue":"1","key":"448_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11046-018-0299-9","volume":"184","author":"S Hagiwara","year":"2019","unstructured":"Hagiwara S, Tamura T, Satoh K, Kamewada H, Nakano M, Shinden S, et al. The molecular identification and antifungal susceptibilities of Aspergillus species causing otomycosis in Tochigi, Japan. Mycopathologia. 2019;184(1):13\u2013211. https:\/\/doi.org\/10.1007\/s11046-018-0299-9.","journal-title":"Mycopathologia"},{"issue":"2","key":"448_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11046-012-9529-8","volume":"174","author":"G Szigeti","year":"2012","unstructured":"Szigeti G, Kocsube S, Doczi I, Bereczki L, Vagvolgyi C, Varga J. Molecular identification and antifungal susceptibilities of black Aspergillus isolates from otomycosis cases in Hungary. Mycopathologia. 2012;174(2):143\u20137. https:\/\/doi.org\/10.1007\/s11046-012-9529-8.","journal-title":"Mycopathologia"},{"issue":"9","key":"448_CR17","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1128\/JCM.00536-10","volume":"48","author":"A Espinel-Ingroff","year":"2010","unstructured":"Espinel-Ingroff A, Diekema DJ, Fothergill A, Johnson E, Pelaez T, Pfaller MA, et al. Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38\u2013A2 document). J Clin Microbiol. 2010;48(9):3251\u20137325325. https:\/\/doi.org\/10.1128\/JCM.00536-10.","journal-title":"J Clin Microbiol"},{"issue":"9","key":"448_CR18","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1128\/AAC.01287-13","volume":"57","author":"A Alastruey-Izquierdo","year":"2013","unstructured":"Alastruey-Izquierdo A, Mellado E, Pelaez T, Peman J, Zapico S, Alvarez M, et al. Population-based survey of filamentous fungi and antifungal resistance in spain (FILPOP study). Antimicrob Agents Chemother. 2013;57(9):4604. https:\/\/doi.org\/10.1128\/AAC.01287-13.","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"448_CR19","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1038\/emi.2017.97","volume":"6","author":"S Deng","year":"2017","unstructured":"Deng S, Zhang L, Ji Y, Verweij PE, Tsui KM, Hagen F, et al. Triazole phenotypes and genotypic characterization of clinical Aspergillus fumigatus isolates in China. Emerg Microbes Infect. 2017;6(12):e109. https:\/\/doi.org\/10.1038\/emi.2017.97.","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"448_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1258\/002221503321046621","volume":"117","author":"KM Ozcan","year":"2003","unstructured":"Ozcan KM, Ozcan M, Karaarslan A, Karaarslan F. Otomycosis in Turkey: predisposing factors, aetiology and therapy. J Laryngol Otol. 2003;117(1):39\u201342. https:\/\/doi.org\/10.1258\/002221503321046621.","journal-title":"J Laryngol Otol"},{"issue":"10","key":"448_CR21","doi-asserted-by":"publisher","first-page":"4802","DOI":"10.1128\/AAC.00304-11","volume":"55","author":"SJ Howard","year":"2011","unstructured":"Howard SJ, Harrison E, Bowyer P, Varga J, Denning DW. Cryptic species and azole resistance in the Aspergillus niger complex. Antimicrob Agents Chemother. 2011;55(10):4802\u20139. https:\/\/doi.org\/10.1128\/AAC.00304-11.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"448_CR22","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/mmy\/myu006","volume":"52","author":"R Sabino","year":"2014","unstructured":"Sabino R, Verissimo C, Parada H, Brandao J, Viegas C, Carolino E, et al. Molecular screening of 246 Portuguese Aspergillus isolates among different clinical and environmental sources. Med Mycol. 2014;52(5):519\u201329. https:\/\/doi.org\/10.1093\/mmy\/myu006.","journal-title":"Med Mycol"},{"issue":"2","key":"448_CR23","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1128\/JCM.03233-14","volume":"53","author":"Y Li","year":"2015","unstructured":"Li Y, Wan Z, Liu W, Li R. Identification and susceptibility of Aspergillus section nigri in china: prevalence of species and paradoxical growth in response to echinocandins. J Clin Microbiol. 2015;53(2):702\u20135. https:\/\/doi.org\/10.1128\/JCM.03233-14.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"448_CR24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.diagmicrobio.2015.10.027","volume":"84","author":"CC Tsang","year":"2016","unstructured":"Tsang CC, Hui TW, Lee KC, Chen JH, Ngan AH, Tam EW, et al. Genetic diversity of Aspergillus species isolated from onychomycosis and Aspergillus hongkongensis sp. nov., with implications to antifungal susceptibility testing. Diagn Microbiol Infect Dis. 2016;84(2):125\u201334. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2015.10.027.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"448_CR25","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1439-0507.2011.02049.x","volume":"55","author":"MBH Hendrickx","year":"2012","unstructured":"Hendrickx MBH, Detandt M. Genetic re-identification and antifungal susceptibility testing of Aspergillus section Nigri strains of the BCCM\/IHEM collection. Mycoses. 2012;55(2):148\u201355. https:\/\/doi.org\/10.1111\/j.1439-0507.2011.02049.x.","journal-title":"Mycoses"},{"issue":"10","key":"448_CR26","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1128\/AAC.00585-09","volume":"53","author":"L Alcazar-Fuoli","year":"2009","unstructured":"Alcazar-Fuoli L, Mellado E, Alastruey-Izquierdo A, Cuenca-Estrella M, Rodriguez-Tudela JL. Species identification and antifungal susceptibility patterns of species belonging to Aspergillus section Nigri. Antimicrob Agents Chemother. 2009;53(10):4514\u20137. https:\/\/doi.org\/10.1128\/AAC.00585-09.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5\u20136","key":"448_CR27","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s11046-014-9775-z","volume":"178","author":"A Alastruey-Izquierdo","year":"2014","unstructured":"Alastruey-Izquierdo A, Alcazar-Fuoli L, Cuenca-Estrella M. Antifungal susceptibility profile of cryptic species of Aspergillus. Mycopathologia. 2014;178(5\u20136):427\u201333. https:\/\/doi.org\/10.1007\/s11046-014-9775-z.","journal-title":"Mycopathologia"},{"issue":"8","key":"448_CR28","doi-asserted-by":"publisher","first-page":"e02583","DOI":"10.1128\/AAC.02583-16","volume":"61","author":"A Hashimoto","year":"2017","unstructured":"Hashimoto A, Hagiwara D, Watanabe A, Yahiro M, Yikelamu A, Yaguchi T, et al. Drug Sensitivity and Resistance Mechanism in Aspergillus Section Nigri Strains from Japan. Antimicrob Agents Chemother. 2017;61(8):e02583\u2013e2616. https:\/\/doi.org\/10.1128\/AAC.02583-16.","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"448_CR29","doi-asserted-by":"publisher","first-page":"5778","DOI":"10.1128\/AAC.01141-13","volume":"57","author":"L Gregson","year":"2013","unstructured":"Gregson L, Goodwin J, Johnson A, McEntee L, Moore CB, Richardson M, et al. In vitro susceptibility of Aspergillus fumigatus to isavuconazole: correlation with itraconazole, voriconazole, and posaconazole. Antimicrobial Agents Chemother. 2013;57(11):5778\u2013800. https:\/\/doi.org\/10.1128\/AAC.01141-13.","journal-title":"Antimicrobial Agents Chemother"},{"issue":"11","key":"448_CR30","doi-asserted-by":"publisher","first-page":"5426","DOI":"10.1128\/AAC.01111-13","volume":"57","author":"SJ Howard","year":"2013","unstructured":"Howard SJ, Lass-Florl C, Cuenca-Estrella M, Gomez-Lopez A, Arendrup MC. Determination of isavuconazole susceptibility of Aspergillus and Candida species by the EUCAST method. Antimicrobial Agents Chemother. 2013;57(11):5426\u201331. https:\/\/doi.org\/10.1128\/AAC.01111-13.","journal-title":"Antimicrobial Agents Chemother"},{"issue":"12","key":"448_CR31","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S1473-3099(09)70265-8","volume":"9","author":"PE Verweij","year":"2009","unstructured":"Verweij PE, Snelders E, Kema GH, Mellado E, Melchers WJ. Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use? Lancet Infect Dis. 2009;9(12):789\u201395. https:\/\/doi.org\/10.1016\/S1473-3099(09)70265-8.","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"448_CR32","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.1128\/JCM.41.12.5525-5529.2003","volume":"41","author":"JW Baddley","year":"2003","unstructured":"Baddley JW, Pappas PG, Smith AC, Moser SA. Epidemiology of Aspergillus terreus at a university hospital. J Clin Microbiol. 2003;41(12):5525\u20139.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"448_CR33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1365-2141.2005.05763.x","volume":"131","author":"C Lass-Florl","year":"2005","unstructured":"Lass-Florl C, Griff K, Mayr A, Petzer A, Gastl G, Bonatti H, et al. Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Br J Haematol. 2005;131(2):201\u20137. https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05763.x.","journal-title":"Br J Haematol"},{"issue":"11","key":"448_CR34","doi-asserted-by":"publisher","first-page":"5150","DOI":"10.1128\/AAC.00686-11","volume":"55","author":"A Espinel-Ingroff","year":"2011","unstructured":"Espinel-Ingroff A, Cuenca-Estrella M, Fothergill A, Fuller J, Ghannoum M, Johnson E, et al. Wild-type MIC distributions and epidemiological cutoff values for amphotericin B and Aspergillus spp. for the CLSI broth microdilution method (M38\u2013A2 document). Antimicrob Agents Chemother. 2011;55(11):5150\u20134. https:\/\/doi.org\/10.1128\/AAC.00686-11.","journal-title":"Antimicrob Agents Chemother"},{"key":"448_CR35","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3389\/fmicb.2018.00516","volume":"9","author":"T Zoran","year":"2018","unstructured":"Zoran T, Sartori B, Sappl L, Aigner M, Sanchez-Reus F, Rezusta A, et al. Azole-resistance in Aspergillus terreus and related species: an emerging problem or a rare phenomenon? Front Microbiol. 2018;9:516. https:\/\/doi.org\/10.3389\/fmicb.2018.00516.","journal-title":"Front Microbiol"},{"issue":"8","key":"448_CR36","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1128\/AAC.00636-13","volume":"57","author":"A Espinel-Ingroff","year":"2013","unstructured":"Espinel-Ingroff A, Chowdhary A, Gonzalez GM, Lass-Florl C, Martin-Mazuelos E, Meis J, et al. Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for Aspergillus spp. for the CLSI M38\u2013A2 broth microdilution method. Antimicrob Agents Chemother. 2013;57(8):3823\u20138. https:\/\/doi.org\/10.1128\/AAC.00636-13.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"448_CR37","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1128\/AAC.01530-08","volume":"53","author":"S Perkhofer","year":"2009","unstructured":"Perkhofer S, Lechner V, Lass-Florl C. European Committee on Antimicrobial Susceptibility T. In vitro activity of Isavuconazole against Aspergillus species and zygomycetes according to the methodology of the European Committee on Antimicrobial Susceptibility Testing. Antimicrob Agents Chemother. 2009;53(4):1645\u20137. https:\/\/doi.org\/10.1128\/AAC.01530-08.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"448_CR38","doi-asserted-by":"publisher","first-page":"e583","DOI":"10.1111\/j.1439-0507.2010.01996.x","volume":"54","author":"MR Shivaprakash","year":"2011","unstructured":"Shivaprakash MR, Geertsen E, Chakrabarti A, Mouton JW, Meis JF. In vitro susceptibility of 188 clinical and environmental isolates of Aspergillus flavus for the new triazole isavuconazole and seven other antifungal drugs. Mycoses. 2011;54(5):e583\u2013e589589. https:\/\/doi.org\/10.1111\/j.1439-0507.2010.01996.x.","journal-title":"Mycoses"},{"issue":"5","key":"448_CR39","doi-asserted-by":"publisher","first-page":"e00004","DOI":"10.1128\/AAC.00004-17","volume":"61","author":"M Taghizadeh-Armaki","year":"2017","unstructured":"Taghizadeh-Armaki M, Hedayati MT, Ansari S, Omran SM, Saber S, Rafati H, et al. Genetic diversity and in vitro antifungal susceptibility of 200 clinical and environmental Aspergillus flavus isolates. Antimicrob Agents Chemother. 2017;61(5):e00004\u201317. https:\/\/doi.org\/10.1128\/AAC.00004-17.","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"448_CR40","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1128\/JCM.00535-08","volume":"46","author":"MA Pfaller","year":"2008","unstructured":"Pfaller MA, Messer SA, Boyken L, Rice C, Tendolkar S, Hollis RJ, et al. In vitro survey of triazole cross-resistance among more than 700 clinical isolates of Aspergillus species. J Clin Microbiol. 2008;46(8):2568\u201372. https:\/\/doi.org\/10.1128\/JCM.00535-08.","journal-title":"J Clin Microbiol"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-020-00448-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11046-020-00448-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-020-00448-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T08:54:29Z","timestamp":1626339269000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11046-020-00448-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,28]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["448"],"URL":"https:\/\/doi.org\/10.1007\/s11046-020-00448-7","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,28]]},"assertion":[{"value":"27 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}